OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

REGISTERED CHARITY NUMBER: 257199

Report of the Trustees and

Unaudited Financial Statements

for the Year Ended 31 December 2025

for BRITISH ASS. OF HEAD & NECK ONCOLOGISTS

Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB

BRITISH ASS. OF HEAD & NECK ONCOLOGISTS

Contents of the Financial Statements for the Year Ended 31 December 2025

----- Start of picture text -----
Page
Report of the Trustees 1 to 2
Independent Examiner's Report 3
Statement of Financial Activities 4
Balance Sheet 5
Notes to the Financial Statements 6 to 12
Detailed Statement of Financial Activities 13 to 14
----- End of picture text -----

BRITISH ASS. OF HEAD & NECK ONCOLOGISTS

Report of the Trustees for the Year Ended 31 December 2025

The trustees present their report with the financial statements of the charity for the year ended 31 December 2025. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

OBJECTIVES AND ACTIVITIES Public benefit

BAHNO continues to meet its public benefit requirement by:

ACHIEVEMENTS AND PERFORMANCE

Charitable activities

BAHNO has successfully transitioned from a period of capital accumulation to a phase of strategic investment. Most notably, the association has committed and begun the rollout of a significant financial investment into a new National Head and Neck Audit, providing a vital platform for clinical communication and data across the specialty. We have significantly increased our direct support to members, awarding substantial research and travel grants, including support for a 12-month fellowship in reconstructive microsurgery.

FUTURE PLANS

We aim that annual income from a flourishing membership and a successful annual conference is directly reinvested into member benefits. Key priorities for the coming year include:

STRUCTURE, GOVERNANCE AND MANAGEMENT

Governing document

The charity is controlled by its governing document, a deed of trust and constitutes an unincorporated charity.

Risk management

The trustees have a duty to identify and review the risks to which the charity is exposed and to ensure appropriate controls are in place to provide reasonable assurance against fraud and error.

Page 1

BRITISH ASS. OF HEAD & NECK ONCOLOGISTS

Report of the Trustees

for the Year Ended 31 December 2025

REFERENCE AND ADMINISTRATIVE DETAILS Registered Charity number 257199

Principal address

BAHNO Secretariat PO Box 9238 Sturminster Newton Dorset DT10 9BR

Trustees

Mr C Hughes Mr S Winter Professor A Schache Mr D Hamilton Professor C M Nutting

On the 16 May 2025, Chris Nutting was appointed as president and Ceri Hughes as immediate past president.

Independent Examiner

Ryan Cottington Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB

Approved by order of the board of trustees on 1 May 2026 and signed on its behalf by:

Mr D Hamilton - Trustee

Page 2

Independent Examiner's Report to the Trustees of British Ass. of Head & Neck Oncologists

Independent examiner's report to the trustees of British Ass. of Head & Neck Oncologists

I report to the charity trustees on my examination of the accounts of British Ass. of Head & Neck Oncologists (the Trust) for the year ended 31 December 2025.

Responsibilities and basis of report

As the charity trustees of the Trust you are responsible for the preparation of the accounts in accordance with the requirements of the Charities Act 2011 ('the Act').

I report in respect of my examination of the Trust's accounts carried out under Section 145 of the Act and in carrying out my examination I have followed all applicable Directions given by the Charity Commission under Section 145(5)(b) of the Act.

Independent examiner's statement

I have completed my examination. I confirm that no material matters have come to my attention in connection with the examination giving me cause to believe that in any material respect:

  1. accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or

  2. the accounts do not accord with those records; or

  3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.

Ryan Cottington

Sandison Lang Limited 2 St Marys Road Tonbridge Kent TN9 2LB

1 May 2026

Page 3

BRITISH ASS. OF HEAD & NECK ONCOLOGISTS

Statement of Financial Activities

for the Year Ended 31 December 2025

Unrestricted
Restricted
fund
fund
Notes
£
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
181,066
40,000
Other trading activities
2
18,289
-
Investment income
3
1,093
-
Total
200,448
40,000
EXPENDITURE ON
Charitable activities
Charitable activities
50,049
-
Other
171,112
11,429
Total
221,161
11,429
NET INCOME/(EXPENDITURE)
(20,713)
28,571
RECONCILIATION OF FUNDS
Total funds brought forward
115,126
-
TOTAL FUNDS CARRIED FORWARD
94,413
28,571
2025
Total
funds
£
221,066
18,289
1,093
240,448
50,049
182,541
232,590
7,858
115,126
122,984
2024
Total
funds
£
30,597
-
787
31,384
30,559
1,638
32,197
(813)
115,939
115,126

The notes form part of these financial statements

Page 4

BRITISH ASS. OF HEAD & NECK ONCOLOGISTS

Balance Sheet

31 December 2025

Unrestricted
Restricted
fund
fund
Notes
£
£
FIXED ASSETS
Tangible assets
6
51
-
CURRENT ASSETS
Stocks
7
2,031
-
Debtors
8
-
28,571
Cash at bank
93,700
-
95,731
28,571
CREDITORS
Amounts falling due within one year
9
(1,369)
-
NET CURRENT ASSETS
94,362
28,571
TOTAL ASSETS LESS CURRENT LIABILITIES
94,413
28,571
NET ASSETS
94,413
28,571
FUNDS
10
Unrestricted funds
Restricted funds
TOTAL FUNDS
2025
Total
funds
£
51
2,031
28,571
93,700
124,302
(1,369)
122,933
122,984
122,984
94,413
28,571
122,984
2024
Total
funds
£
51
200
-
116,171
116,371
(1,296)
115,075
115,126
115,126
115,126
-
115,126

The financial statements were approved by the Board of Trustees and authorised for issue on 1 May 2026 and were signed on its behalf by:

Mr D Hamilton - Trustee

The notes form part of these financial statements

Page 5

BRITISH ASS. OF HEAD & NECK ONCOLOGISTS

Notes to the Financial Statements for the Year Ended 31 December 2025

1. ACCOUNTING POLICIES

Basis of preparing the financial statements

The financial statements of the charity, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Charities Act 2011. The financial statements have been prepared under the historical cost convention.

Income

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment - 25% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

The charity is exempt from tax on its charitable activities.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

continued...

Page 6

BRITISH ASS. OF HEAD & NECK ONCOLOGISTS

Notes to the Financial Statements - continued for the Year Ended 31 December 2025

1. ACCOUNTING POLICIES - continued

Fund accounting

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

Pension costs and other post-retirement benefits

The charity operates a defined contribution pension scheme. Contributions payable to the charity's pension scheme are charged to the Statement of Financial Activities in the period to which they relate.

2. OTHER TRADING ACTIVITIES

Fundraising events
3.
INVESTMENT INCOME
Deposit account interest
2025
£
18,289
2025
£
1,093
2024
£
-
2024
£
787

4. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31 December 2025 nor for the year ended 31 December 2024.

5.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricted
Restricted
fund
fund
£
£
INCOME AND ENDOWMENTS FROM
Donations and legacies
30,597
-
Investment income
787
-
Total
31,384
-
EXPENDITURE ON
Charitable activities
Charitable activities
30,559
-
Other
1,638
-
Total
32,197
-
Total
funds
£
30,597
787
31,384
30,559
1,638
32,197

continued...

Page 7

BRITISH ASS. OF HEAD & NECK ONCOLOGISTS

Notes to the Financial Statements - continued for the Year Ended 31 December 2025

----- Start of picture text -----
5. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued
Unrestricted Restricted Total
fund fund funds
£ £ £
-
NET INCOME/(EXPENDITURE) (813) (813)
RECONCILIATION OF FUNDS
-
Total funds brought forward 115,939 115,939
TOTAL FUNDS CARRIED FORWARD 115,126 - 115,126
6. TANGIBLE FIXED ASSETS
Computer
equipment
£
COST
At 1 January 2025 and
31 December 2025 967
DEPRECIATION
At 1 January 2025 and
31 December 2025 916
NET BOOK VALUE
At 31 December 2025 51
At 31 December 2024 51
----- End of picture text -----

continued...

Page 8

BRITISH ASS. OF HEAD & NECK ONCOLOGISTS

Notes to the Financial Statements - continued for the Year Ended 31 December 2025

----- Start of picture text -----
7. STOCKS
2025 2024
£ £
Stock of medals 2,031 200
8. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Other debtors 28,571 -
9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Taxation and social security (29) (29)
Other creditors 1,398 1,325
1,369 1,296
10. MOVEMENT IN FUNDS
Net
movement At
At 1/1/25 in funds 31/12/25
£ £ £
Unrestricted funds
General fund 115,126 (20,713) 94,413
Restricted funds
Audit Costs - 28,571 28,571
TOTAL FUNDS 115,126 7,858 122,984
----- End of picture text -----

continued...

Page 9

BRITISH ASS. OF HEAD & NECK ONCOLOGISTS

Notes to the Financial Statements - continued for the Year Ended 31 December 2025

10. MOVEMENT IN FUNDS - continued

Net movement in funds, included in the above are as follows:

Incoming
resources
£
Unrestricted funds
General fund
200,448
Restricted funds
Audit Costs
40,000
Resources
expended
£
(221,161)
(11,429)
Movement
in funds
£
(20,713)
28,571
TOTAL FUNDS
240,448
(232,590) 7,858
Comparatives for movement in funds
At 1/1/24
£
Unrestricted funds
General fund
115,939
Net
movement
in funds
£
(813)
At
31/12/24
£
115,126
TOTAL FUNDS
115,939
(813) 115,126
Comparative net movement in funds, included in the above are as follows:
Incoming
Resources
resources
expended
£
£
Unrestricted funds
General fund
31,384
(32,197)
Movement
in funds
£
(813)
TOTAL FUNDS
31,384
(32,197) (813)

continued...

Page 10

BRITISH ASS. OF HEAD & NECK ONCOLOGISTS

Notes to the Financial Statements - continued for the Year Ended 31 December 2025

10. MOVEMENT IN FUNDS - continued

A current year 12 months and prior year 12 months combined position is as follows:

At 1/1/24
£
Unrestricted funds
General fund
115,939
Restricted funds
Audit Costs
-
Net
movement
At
in funds
31/12/25
£
£
(21,526)
94,413
28,571
28,571
TOTAL FUNDS
115,939
7,045
122,984

A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:

Unrestricted funds
General fund
Restricted funds
Audit Costs
Incoming
Resources
resources
expended
£
£
231,832
(253,358)
40,000
(11,429)
Movement
in funds
£
(21,526)
28,571
TOTAL FUNDS 271,832
(264,787)
7,045

continued...

Page 11

BRITISH ASS. OF HEAD & NECK ONCOLOGISTS

Notes to the Financial Statements - continued for the Year Ended 31 December 2025

11. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 31 December 2025.

Page 12

BRITISH ASS. OF HEAD & NECK ONCOLOGISTS

Detailed Statement of Financial Activities for the Year Ended 31 December 2025

INCOME AND ENDOWMENTS
Donations and legacies
Donations
Grants
Subscriptions
Other trading activities
Fundraising events
Investment income
Deposit account interest
Total incoming resources
EXPENDITURE
Charitable activities
Salaries
Pensions
Subscriptions
AGM expenses
Telephone
Postage and stationery
Medals expenses and engraving
Computer and website expenses
Research and travel awards
Support costs
Management
Annual audit payment
Sundries
Oracle supplier delivery costs
2025
£
149,000
40,000
32,066
221,066
18,289
1,093
240,448
13,129
178
2,143
7,403
59
58
200
5,635
12,011
40,816
182,541
1,673
5,000
189,214
2024
£
1
-
30,596
30,597
-
787
31,384
12,950
202
235
-
70
292
613
6,413
8,539
29,314
-
1,245
-
1,245

This page does not form part of the statutory financial statements

Page 13

BRITISH ASS. OF HEAD & NECK ONCOLOGISTS

Detailed Statement of Financial Activities for the Year Ended 31 December 2025

Management
Finance
Bank charges
Governance costs
Accountancy
Depreciation of tangible fixed assets
Total resources expended
Net income/(expenditure)
2025
£
458
2,102
-
2,102
232,590
7,858
2024
£
-
1,587
51
1,638
32,197
(813)

This page does not form part of the statutory financial statements

Page 14